Acorda Therapeutics (ACOR): Q4 EPS of -$0.59 in-line. Revenue of $14.4M (+15.9%) vs. $14.8M. (PR)

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor
Acorda Therapeutics (ACOR): Q4 EPS of -$0.59 in-line. Revenue of $14.4M (+15.9%) vs. $14.8M. (PR)